An optically active bis-chelated complex, [Ru(bipy)2Cl2](bipy = 2,2′-bipyridyl), has been obtained when enantiomeric [Ru(bipy)3]Cl2 was illuminated by visible light in dichloromethane. From the dependence of the optical purity of the product on light intensity, it is proposed that the reaction from Δ-[Ru(bipy)3]Cl2 to Δ-[Ru(bipy)2Cl2](chirality retention) proceeds by way of the dissociation of a monodentate ligand, bipy*, from a photoactivated intermediate, Δ-[Ru(bipy)2(bipy*)Cl]Cl in the dark, while the reaction to Λ-[Ru(bipy)2Cl2](chirality inversion) involves the further photoactivated configurational change of Δ-[Ru(bipy)2(bipy*)Cl]Cl to Λ-[Ru(bipy)2(bipy*)Cl]Cl. Racemization is avoided under the conditions of weak light and high temperature. The synthetic value of optically active [Ru(bipy)2Cl2] as a chiral intermediate has been exemplified by preparing a new chiral amphiphilic ruthenium(II) complex.
No takes yet. Share an insight, caveat, or question.
Yamagishi et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: